Mitch Goldman MD, PhD in

Mitch Goldman MD, PhD

Energizer · DISC type I
SVP Head of Research and Development, Global Rare Diseases at Chiesi Group
📍 Philadelphia, Pennsylvania, United States

Mitch Goldman is a physician-scientist serving as the SVP and Head of Research and Development for Global Rare Diseases at Chiesi Group. With extensive experience in the pharmaceutical industry, he specializes in translational medicine, biomarker development, and leading cross-functional teams from early development to medical affairs. He earned his MD and PhD from Case Western Reserve University.

He has a deep expertise in developing therapies for rare conditions, including pulmonary, rheumatology, and autoimmune diseases. He has overseen the development of small molecules, biologics, and gene therapies, navigating multiple health authorities. He has contributed to over 40 publications in prestigious peer-reviewed journals.

He is focused on advancing scientific understanding and incorporating patient experiences into developing holistic solutions for the rare disease community.

Read the full overview →
Experience
36 Years
Current Role
SVP Head of Research and Development, Global Rare Diseases
Job Level
Leadership
Location
Philadelphia, Pennsylvania, United States
Personality Overview

How Mitch shows up

Imaginative
Informal
Enthusiastic

They are not always early adopters but can be pursuaded by leveraging strong relationships. They are friendly, approachable and love to make new connections. They are always positive and upbeat, so take their promises with a pinch of salt.

Priorities

Topics Mitch cares about

Rare Disease Therapies
Leads R&D for Global Rare Diseases at Chiesi, focusing on advancing therapies for conditions like Fabry disease, alpha-mannosidosis, and lysosomal storage disorders.
Patient-Reported Outcomes
Emphasizes combining clinical research with insights from patients and caregivers to develop more holistic solutions for the rare disease community.
+5 more topics Login to view topics
Career

Work history

9-2024
SVP Head of Research and Development, Global Rare Diseases
Chiesi Group
6-2021 - 9-2024
Chief Medical Officer
Amicus Therapeutics
2-2020 - 6-2021
Senior Vice President Clinical
Amicus Therapeutics
2017 - 1-2020
Vice President Late Stage Biologics for Respiratory, Autoimmune, and Anti-infectives
AstraZeneca
2012 - 2017
Executive Director Global Medicine
AstraZeneca
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1989
Doctor of Medicine (MD)
Case Western Reserve University
1985
Doctor of Philosophy (PhD)
Case Western Reserve University
1980
BA
University of Colorado Boulder
Social presence
in
Behavioral profile

DISC profile (public)

I

Influence (I)

Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.

Other Chiesi Group Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Mitch. Free, 10 seconds.